News

Morgan Stanley said the FDA proposal yesterday “came as a surprise to most investors (and us) and clearly adds additional uncertainty” for Charles River (CRL) Laboratories at a time when the ...
CNBC's Leslie Picker reports on Morgan Stanley's quarterly earnings results. Airports set to scrap boarding passes and check-ins in major travel shake-up Volcano alert after 160 earthquakes strike ...
(Reuters) -Morgan Stanley beat first-quarter profit estimates ... and over what periods. Wall Street's investment banks face a murky dealmaking climate. A rebound in Asia helped lift global ...
Morgan Stanley MS will release earnings results for the first quarter, before the opening bell on Friday, April 11. Analysts expect the New York-based bank to report quarterly earnings at $2.19 ...
(CNN) — King Charles and Queen Camilla paid a surprise visit to Pope Francis as he recuperates at the Vatican on Wednesday during a state visit to Italy that coincided with the British royal ...
'Making Money' host analyzes the stock market's double-digit revival after President Donald Trump's tariff pause. Four Democrats join Republicans to pass SAVE Act bill that requires proof of ...
St. Charles Health System tops the list again, employing 5,188 people regionwide, an 8.29% increase since last year at the same time. The top five private traded-sector businesses, those that ...
On April 9, 2025, Peloton (PTON) Interactive announced that Charles Kirol had been appointed ... Mr. Kirol served in executive roles at Stanley Black & Decker, Inc., including as Vice President ...
Morgan Stanley raised the firm’s price target on AT&T to $30 from $28 and keeps an Overweight rating on the shares. The firm estimates that better-than-expected Q4 U.S. wireless net additions ...
TD Cowen analyst Bill Katz lowered the firm’s price target on Charles Schwab to $88 from $103 and keeps a Buy rating on the shares. Ahead of the Q1 reports, the firm reduced estimates for asset ...
Morgan Stanley analyst Rahul Anand maintained a Hold rating on 29metals Ltd. (29M – Research Report) today and set a price target of A$0.13. The company’s shares opened today at A$0.12.